Latest Kidney Cancer News
Kidney Cancer News elsewhere on the Web
Dr Bowman discusses immune-related and TKI-specific toxicities when combining immunotherapy and TKIs in non–clear cell RCC.
Regina Barragan-Carrillo, MD, evaluates the current state of the global availability of clinical trials for patients with renal cell carcinoma.
The European Commission must issue a decision on the application on or by June 2, 2025.
There were a number of notable developments for patients with kidney cancer at the symposium, Dr. Emre Yekedüz explained.
Lifetime excess body weight and significant weight gain in adulthood are associated with an increased risk for renal cell carcinoma, while weight loss is linked to a lower risk.
Dr Braun discusses molecular factors that contribute to exceptional immune checkpoint inhibition responses among patients with renal cell carcinoma.
The first study of personalized cancer vaccines for renal cell carcinoma with breakthrough results in the adjuvant setting has been published, showing a 100% efficacy rate and negligible toxic effects. However, important questions remain concerning long-term effectiveness.
Many patients with metastatic clear cell renal cell carcinoma (ccRCC) are not receiving immune checkpoint inhibitors (ICIs) as first-line therapy, ...
Sid Sadler discusses kidney cancer awareness, patient advocacy and the need for specialized care to improve access to treatments and clinical trials.
Background: Ferroptosis-related genes are essential in cancer development.However, the specific roles of ferroptosis-related genes in clear cell renal cell c...
No results found.
Articles from Kidney Cancer UK
No results found.
No results found.